Differential Expression of Granulopoiesis Related Genes in Neutrophil Subsets Distinguished by Membrane Expression of CD177

Objective Differential gene expression in CD177+ and CD177− neutrophils was investigated, in order to detect possible differences in neutrophil function which could be related to the pathogenesis of ANCA-associated Vasculitides (AAV). Methods Neutrophils were isolated from healthy controls (HC) with high, negative or bimodal CD177 expression, and sorted into CD177+ and CD177− subpopulations. Total RNA was screened for expression of 24,000 probes with Illumina Ref-8 Beadchips. Genes showing differential expression between CD177+ and CD177− subsets in microarray analysis were re-assessed using quantitative-PCR. CD177 expression on neutrophil precursors in bone marrow was analyzed using quantitative PCR and flowcytometry. Results The proportion of CD177+ cells increased during neutrophil maturation in bone marrow. Fold change analysis of gene expression profile of sorted CD177+ and CD177− neutrophils resulted in 14 genes with fold change (fc) >3 difference in expression. Interestingly, 10 of these genes have been reported to change significantly in expression during neutrophil maturation, and most of these genes were granule protein (GP) coding genes. mRNA expression levels measured by RT-PCR of a number of these GP, and of PR3 and MPO were higher in the CD177− neutrophil subset in HC, however, particular granule protein amounts were comparable between CD177+ and CD177− neutrophil subsets. AAV patients had higher amounts of CD177+ neutrophils, but contrary to neutrophils from HC expression of GP-genes was increased, possibly due to activation. Conclusion The neutrophil population can be distinguished by membrane expression of CD177 into subsets that are different in expression of GP mRNA but not in GP protein production. GP gene expression is also elevated in AAV patients, which is not explained by skewed distribution of CD177+ and CD177− subsets but may be associated with neutrophil activation during on-going inflammation.

[1]  H. Meyerson,et al.  CD177 expression on neutrophils: in search of a clonal assay for myeloid neoplasia by flow cytometry. , 2013, American journal of clinical pathology.

[2]  M. Menshikov,et al.  Comparative evaluation of the role of the adhesion molecule CD177 in neutrophil interactions with platelets and endothelium , 2012, European journal of haematology.

[3]  A. Bengtsson,et al.  Decreased Neutrophil Apoptosis in Quiescent ANCA-Associated Systemic Vasculitis , 2012, PloS one.

[4]  B. Porse,et al.  Technical Advance: Immunophenotypical characterization of human neutrophil differentiation , 2011, Journal of leukocyte biology.

[5]  Min Chen,et al.  ANCA-associated vasculitides—advances in pathogenesis and treatment , 2010, Nature Reviews Rheumatology.

[6]  T. Magnuson,et al.  Epigenetic basis for aberrant upregulation of autoantigen genes in humans with ANCA vasculitis. , 2010, The Journal of clinical investigation.

[7]  A. Bengtsson,et al.  Elevated neutrophil membrane expression of proteinase 3 is dependent upon CD177 expression , 2010, Clinical and experimental immunology.

[8]  F. Costa,et al.  Molecular studies reveal that A134T, G156A and G1333A SNPs in the CD177 gene are associated with atypical expression of human neutrophil antigen‐2 , 2010, Vox sanguinis.

[9]  Francisco Tirado,et al.  GeneCodis: interpreting gene lists through enrichment analysis and integration of diverse biological information , 2009, Nucleic Acids Res..

[10]  C. Kallenberg,et al.  Coexpression of CD177 and membrane proteinase 3 on neutrophils in antineutrophil cytoplasmic autoantibody-associated systemic vasculitis: anti-proteinase 3-mediated neutrophil activation is independent of the role of CD177-expressing neutrophils. , 2009, Arthritis and rheumatism.

[11]  C. Kallenberg,et al.  Skewed distribution of Th17 lymphocytes in patients with Wegener's granulomatosis in remission. , 2008, Arthritis and rheumatism.

[12]  Yoshihiro Yamanishi,et al.  KEGG for linking genomes to life and the environment , 2007, Nucleic Acids Res..

[13]  J. Issa,et al.  Epigenetic control of PRV-1 expression on neutrophils. , 2007, Experimental hematology.

[14]  K. Preissner,et al.  The Neutrophil-specific Antigen CD177 Is a Counter-receptor for Platelet Endothelial Cell Adhesion Molecule-1 (CD31)* , 2007, Journal of Biological Chemistry.

[15]  M. Wellner,et al.  NB1 mediates surface expression of the ANCA antigen proteinase 3 on human neutrophils. , 2007, Blood.

[16]  C. Kallenberg,et al.  Standardised assessment of membrane proteinase 3 expression. Analysis in ANCA-associated vasculitis and controls , 2007, Annals of the rheumatic diseases.

[17]  M. Segelmark,et al.  Proteinase 3 and CD177 are expressed on the plasma membrane of the same subset of neutrophils , 2007, Journal of leukocyte biology.

[18]  J. Bux,et al.  Sex‐dependent up regulation of CD177‐specific mRNA expression in cord blood due to different stimuli , 2006, Transfusion.

[19]  F. Nielsen,et al.  The transcriptional program of terminal granulocytic differentiation. , 2004, Blood.

[20]  D. Alcorta,et al.  Circumvention of normal constraints on granule protein gene expression in peripheral blood neutrophils and monocytes of patients with antineutrophil cytoplasmic autoantibody-associated glomerulonephritis. , 2004, Journal of the American Society of Nephrology : JASN.

[21]  U. Sibelius,et al.  Neutrophil CD177 (NB1 gp, HNA‐2a) expression is increased in severe bacterial infections and polycythaemia vera , 2004, British journal of haematology.

[22]  R. Bohle,et al.  Lack of NB1 GP (CD177/HNA-2a) gene transcription in NB1 GP- neutrophils from NB1 GP-expressing individuals and association of low expression with NB1 gene polymorphisms. , 2003, Blood.

[23]  P. Heeringa,et al.  Antineutrophil cytoplasmic autoantibodies specific for myeloperoxidase cause glomerulonephritis and vasculitis in mice. , 2002, The Journal of clinical investigation.

[24]  C. Kallenberg,et al.  Neutrophil membrane expression of proteinase 3 (PR3) is related to relapse in PR3-ANCA-associated vasculitis. , 2002, Journal of the American Society of Nephrology : JASN.

[25]  K. Kissel,et al.  Molecular basis of NB1 (HNA-2a, CD177) deficiency. , 2002, Blood.

[26]  D. Stroncek,et al.  Variations in the expression of granulocyte antigen NB1 , 2000, Transfusion.

[27]  B. Prum,et al.  A large subset of neutrophils expressing membrane proteinase 3 is a risk factor for vasculitis and rheumatoid arthritis. , 1999, Journal of the American Society of Nephrology : JASN.

[28]  Shankar,et al.  The expression of the NB1 antigen on myeloid precursors and neutrophils from children and umbilical cords , 1998, Transfusion medicine.

[29]  V. Witko-Sarsat,et al.  Bimodal distribution of proteinase 3 (PR3) surface expression reflects a constitutive heterogeneity in the polymorphonuclear neutrophil pool , 1995, FEBS letters.

[30]  C. Kallenberg,et al.  Anti-neutrophil cytoplasmic antibodies: current diagnostic and pathophysiological potential. , 1994, Kidney international.

[31]  J. Hoidal,et al.  Specificity of anti-neutrophil cytoplasmic autoantibodies for proteinase 3. , 1990, Blood.

[32]  D. Stroncek,et al.  Biochemical characterization of the neutrophil-specific antigen NB1. , 1990, Blood.

[33]  C. Hack,et al.  Wegener's granulomatosis autoantibodies identify a novel diisopropylfluorophosphate-binding protein in the lysosomes of normal human neutrophils. , 1989, The Journal of clinical investigation.

[34]  R. Falk,et al.  Anti-neutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and crescentic glomerulonephritis. , 1988, The New England journal of medicine.

[35]  P. Merkel,et al.  2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. , 2013, Arthritis and rheumatism.

[36]  M. Segelmark,et al.  Circulating cytokine profile in anti-neutrophilic cytoplasmatic autoantibody-associated vasculitis: prediction of outcome? , 2004, Mediators of inflammation.

[37]  A. Busjahn,et al.  Membrane expression of proteinase 3 is genetically determined. , 2003, Journal of the American Society of Nephrology : JASN.